Anna Panovská

Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group

2020 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové

Publikace